Lymphatic Vessels: The Next Frontier in Lung Transplant

Lung transplantation is the only definitive treatment for end-stage pulmonary diseases, yet long-term graft survival is frequently limited by acute and chronic rejection. A critical, often overlooked factor in this process is the lymphatic system. During the surgical procedure, the pulmonary lymphatic network is inevitably severed, leading to a complete loss of drainage function. This disruption is not merely a technical complication; it creates a pathological environment that contributes to pulmonary edema, immune cell infiltration, and the accumulation of harmful metabolic byproducts.

Under normal physiological conditions, lymphatic vessels maintain tissue homeostasis by draining excess fluid and macromolecules from the interstitium. In the immediate post-transplant period, the lack of lymphatic drainage causes significant edema, which impairs gas exchange and creates a pro-inflammatory environment.

Beyond fluid balance, the lymphatic system is a key regulator of the immune response. While some earlier research suggested that lymphatic vessels might facilitate rejection by transporting antigen-presenting cells to lymph nodes, recent evidence indicates that the absence of functional lymphatics is actually more detrimental. Inadequate drainage leads to the retention of inflammatory cells and pro-inflammatory signals within the graft, worsening the immune-mediated damage.

One of the most significant consequences of lymphatic dysfunction is the accumulation of low-molecular-weight hyaluronan (LMW-HA). While high-molecular-weight HA is essential for structural integrity, LMW-HA acts as a danger signal that triggers intense inflammatory responses. Functional lymphatic vessels, specifically those expressing the receptor LYVE-1, are responsible for clearing these fragments. When lymphatics are damaged, LMW-HA persists, fueling a cycle of inflammation and rejection. Therapeutic strategies that stimulate lymphangiogenesis—such as the administration of VEGF-C—have been shown in animal models to restore this clearance mechanism, thereby mitigating the inflammatory milieu and protecting the graft.